The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.
from NDTV News - Topstories https://ift.tt/3rK0iwU
from NDTV News - Topstories https://ift.tt/3rK0iwU
Comments
Post a Comment